How Substack Creators Are Covering This Strange Markets Era
We closed out our New York live show on May 28 with a panel that featured three of our favorite Substackers: James van Geelen of Citrini Research, Sam Ro, founder of The TKer, and journalist Jasmine Sun. They've all been Odd Lots guests before, and we wanted to get them together to discuss how journalists and analysts are supposed to cover this incredibly strange and highly pressurized moment in markets. Not only has AI basically infected every corner of the world, the media included, but there's just so much news that it's sometimes hard to figure out what the focus should be. But James, Sam, and Jasmine have all found their own niches, and cover AI in a really unique way. This panel discussion debates how the media has covered fears over the AI bubble and the possibility of mass job loss, if people in Silicon Valley are scared about the future of society, if AI can really mimic a writer's voice and personality, and (if they can) how writers can hedge against that future.
Read more:Amazon in Talks to Sell Custom AI Chips in Bid to Undercut NvidiaAI Company Dream Triples Value to $3 Billion in Funding Round
Only http://Bloomberg.com subscribers can get the Odd Lots newsletter in their inbox each week, plus unlimited access to the site and app. Subscribe at bloomberg.com/subscriptions/oddlots
Subscribe to the Odd Lots NewsletterJoin the conversation: discord.gg/oddlots
See omnystudio.com/listener for privacy information.
Will AI Populism Decide the 2028 Election? | Jasmine Sun
AI is no longer just a technology story. It is becoming a political fault line. Jasmine Sun joins Bankless to unpack the rise of AI populism, why backlash against data centers and AI labs is spreading across strange political coalitions, and whether jobs, inequality, and SuperPAC money could turn AI into a defining 2028 election issue.
---
🎬 DEBRIEF | RYAN & DAVID BREAKDOWN THE EPSIODE
https://www.bankless.com/podcast/debrief-will-ai-populism-decide-the-2028-election
---
BANKLESS SPONSOR TOOLS:
🔮POLYMARKET | #1 PREDICTION MARKET
https://bankless.cc/polymarket-podcast
🟦 COINBASE ONE | GET 20% OFF
https://bankless.cc/coinbase-one
🧭OKX | TRADE, EARN, PAY to OKX | 120M+ USERS WORLDWIDE
https://app.okx.com/join/USBANKLESS
🦊 METAMASK | DOWNLOAD NOW
https://go.metamask.io/BL-Pod-Download
🌐BRIX | EMERGING MARKET YIELD
https://bankless.cc/brix
💰NEXO | Get your 30-day access to Wealth Club Premier
https://bankless.cc/nexo
---
TIMESTAMPS
0:00 What Is AI Populism?
2:56 Why AI Could Matter in 2028
11:13 Data Centers, Distrust, and Warning Shots
25:27 The Jobpacalypse Debate
43:25 Game Over for Labor?
51:52 The New AI Political Map
1:04:50 Power Inequality, Policy, and the Grand Bargain
1:18:37 How to Stay Useful in the AI Era
---
RESOURCES
Jasmine Sun
https://x.com/jasminewsun
Jasmine’s Substack
https://substack.com/@jasmine
---
Not financial or tax advice. See our investment disclosures here:
https://www.bankless.com/disclosures
The 'biohacking' trend that has tech workers experimenting on themselves
In an industry known for pushing the bounds of human innovation, tech elites are now trying to push the bounds of their own bodies. The hot new biohacking trend is injectable peptides — similar to the ones found in GLP-1 medications like Ozempic. But these are not approved by the Food and Drug Administration.
These gray-market peptides, largely from Chinese manufacturers, are being used by tech workers and founders. Not just to lose weight, but to optimize their health and performance in all manner of ways. “Marketplace Tech” host Meghan McCarty Carino speaks with independent journalist Jasmine Sun, who recently wrote about this for the New York Times.
The Booming Business of Chinese Peptides
You probably already know someone doing peptides — the amino acids that form the basis of popular new drug treatments like Ozempic and Wegovy. Today there are peptides meant to help with everything from weight loss, to cellular regeneration, to improved eye contact while talking. In San Francisco, there are even organized “peptide raves.” Yet most of these underground peptides haven’t been approved by regulators for human use in the US. So where are they coming from? And how do they get here? On this episode, we speak with two guests who have seen this growing subculture up close, Jasmine Sun, an independent writer covering AI and San Francisco culture, as well as Zak David, managing partner of Pirsek Technologies, which runs a peptide supplier, Peptide Partners.
Subscribe to the Odd Lots Newsletter
Join the conversation: discord.gg/oddlots
See omnystudio.com/listener for privacy information.